Clinical trial
Molecular Ovarian Cancer Assessment in LatiNoAmerican PAtients
NCT07771400 is registered in ClinicalTrials.gov with Latin American Cooperative Oncology Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Molecular Ovarian Cancer Assessment in LatiNoAmerican PAtients
- Lead sponsor
- Latin American Cooperative Oncology Group
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- September 30, 2026
- Completion date
- August 31, 2027
- Enrollment
- 320 (estimated)
- Sites
- 17
Conditions
As the registry lists them; a condition with its own page is linked.
fallopian tube cancer stage iii, fallopian tube cancer stage iv, fallopian tube cancers, ovarian cancer by figo stage, ovarian cancer stage iii, ovarian cancer stage iv